PABLO MARTIN SANZ,巴勃羅‧馬丁‧桑斯,JAVIER URBANO HURTADO,賈維爾‧厄巴諾‧胡塔多
申请号：
HK15105100.9
公开号：
HK1204562A
申请日:
2015.05.28
申请国别(地区):
HK
年份:
2015
代理人:
摘要：
The present invention relates to a pharmaceutical composition which includes a HMG-CoA reductase inhibitor, in particular, a statin and acetylsalicylic acid in a manner to minimize interaction of acetylsalicylic acid with the statin, for use in the prevention or treatment of cardiovascular diseases.
